Abstract
The growth and division of mycobacteria, which include clinically relevant pathogens, deviate from that of canonical bacterial models. Despite their Gram-positive ancestry, mycobacteria synthesize and elongate a diderm envelope asymmetrically from the poles, with the old pole elongating more robustly than the new pole. The phosphatidylinositol-anchored lipoglycans lipomannan (LM) and lipoarabinomannan (LAM) are cell envelope components critical for host-pathogen interactions, but their physiological functions in mycobacteria remained elusive. In this work, using biosynthetic mutants of these lipoglycans, we examine their roles in maintaining cell envelope integrity in Mycobacterium smegmatis and Mycobacterium tuberculosis. We find that mutants defective in producing mature LAM fail to maintain rod cell shape specifically at the new pole and para-septal regions whereas a mutant that produces a larger LAM becomes multi-septated. Therefore, LAM plays critical and distinct roles at subcellular locations associated with division in mycobacteria, including maintenance of local cell wall integrity and septal placement.
Subject terms: Bacteriology, Glycobiology, Pathogens, Cellular microbiology, Glycolipids
Mycobacteria have a unique cell envelope that includes characteristic lipoglycans, such as lipoarabinomannan. Here, Sparks et al. show that this lipoglycan plays roles in maintenance of local cell envelope integrity and septal placement during cell division.
Introduction
Cell envelopes define the shape, growth characteristics, and environmental interactions of bacteria and are broadly classified as Gram-positive or Gram-negative type based on their genetically encoded envelope architecture. Mycobacterium, a medically important genus of actinobacteria, produces an envelope divergent from both of these regimes and consequently has drastically different envelope physiology. The mechanisms that govern mycobacterial cell envelope assembly are only beginning to emerge.
Like most other bacteria, mycobacteria have a plasma membrane and a peptidoglycan cell wall. However, mycobacteria also have an arabinogalactan layer covalently attached to the peptidoglycan, which is also bound to long-chain fatty acids called mycolic acids1–3. These bound mycolic acids support an outer “myco” membrane composed of free mycolic acids and other lipids. Altogether, this envelope architecture is lipid-dense, and includes multiple hydrophobic and hydrophilic layers, making it difficult for antibiotics to reach their targets. The structural divergence of mycobacterial envelopes also extends to the mechanisms used by mycobacteria to synthesize these structures during growth and division. Mycobacteria grow asymmetrically from the poles, with the old pole elongating faster than the new pole formed from the most recent cell septation event4–7. While we have a basic understanding of the order of events during growth and cell division, as well as genes that are involved in the biosynthesis of each component, many of the structural components of the cell envelope have poorly understood physiological functions. Examples include the phosphatidylinositol mannosides (PIMs) and their derivative lipoglycans lipomannan (LM) and lipoarabinomannan (LAM), which are phosphatidylinositol (PI)-anchored membrane components produced by all mycobacteria1.
PIM biosynthesis begins on the inner leaflet of the plasma membrane where the mannosyltransferases PimA and PimB’ sequentially transfer two mannoses from GDP-mannose to the inositol of PI to produce PIM2 (Fig. 1a)8–10. PIM2 is then acylated on one of the mannose residues, and further mannosylated by unknown transferases to produce a tetra-mannosylated glycolipid (AcPIM4). The downstream fate of AcPIM4 is forked: AcPIM4 may either be mannosylated by the α1-2 mannosyltransferase PimE and another uncharacterized mannosyltransferase to form AcPIM611, or AcPIM4 is further mannosylated by α1-6 mannosyltransferases such as MptA to produce LM, a lipoglycan similar to PIMs but with an elongated α1-6 mannose backbone12,13. Decorating the long mannan backbone of LM are multiple α1-2-linked mannoses added by the mannosyltransferase MptC14–16. Finally, a branched arabinan domain may be added to the α1-6 mannan backbone to produce LAM1,2. The biosynthesis of the arabinan domain is carried out by a suite of arabinosyltransferases, including EmbC, as well as some of the Aft transferases, though a detailed understanding of the involvement of each arabinosyltransferase is lacking.
PIMs, LM, and LAM specifically bind host receptors during infection to initiate both pro- and anti-inflammatory responses, as well as to prevent phagosome maturation, ultimately promoting intracellular survival (see reviews17,18). Notably, a recent study identified LamH, a mannosidase that releases LAM from the cell surface to produce capsular arabinomannan, and is crucial for the survival of M. tuberculosis in macrophages19. These studies indicate that PIMs, LM, and LAM are important virulence factors during mycobacterial infection. Moreover, these molecules are widely conserved among all mycobacteria, including many non-pathogenic species, suggesting a more fundamental physiological role in the cell envelope20. A mannose auxotroph of the nonpathogenic Mycobacterium smegmatis becomes shorter and multiseptated when starved for mannose, indicating the physiological importance of mannose-containing molecules such as PIMs, LM, and LAM in cell growth and division21. Consistently, deficiencies in LM and LAM biosynthesis have demonstrated loss-of-fitness phenotypes in axenic culture. For example, overexpression of mptC in M. smegmatis resulted in the truncation of the arabinan and mannan domains of LM and LAM and similar changes in the apparent sizes of LM and LAM are observed in M. tuberculosis16. In both M. smegmatis and M. tuberculosis, mptC overexpression resulted in increased sensitivity to cell wall-targeting antibiotics22. An M. smegmatis mptA deletion mutant producing a small LM-precursor but no mature LM or LAM, grew slowly on solid LB agar medium and failed to grow at 42 °C13. These observations reveal that LM and LAM may play an important role in mycobacterial growth and cell envelope integrity. Whether the phenotypes described in the literature share an etiological mechanism and what that mechanism might be remains unknown.
In this work, to determine the physiological functions of mycobacterial lipoglycans, we generate various mutants of M. smegmatis and M. tuberculosis that are deficient in LM and/or LAM biosynthesis and demonstrate that the arabinan domain of LAM defines the subcellularly localized role of LAM in maintaining cell wall integrity during cell division.
Results
Defective colony growth of ∆mptA is dependent on culture medium
An mptA deletion strain of M. smegmatis has a growth defect when grown on solid LB agar at 37 °C13. This contrasts with our previous observation that an mptA knockdown (KD) strain grows at a rate comparable to wildtype (WT) in Middlebrook 7H9 broth incubated at a lower temperature (30 °C)22, and suggests conditional importance of LM and LAM for mycobacterial survival and growth. To better understand the role of MptA and its products LM and LAM, we generated ∆mptA and confirmed that MptA was not detectable by immunoblotting in ∆mptA (Fig. 1b). Furthermore, ∆mptA did not produce LM or LAM, but instead accumulated a small LM precursor as reported previously13,22 (Fig. 1c). We then grew ∆mptA on two different agar plates, LB or Middlebrook 7H10. As previously observed13, ∆mptA grown on LB agar formed colonies significantly smaller than WT regardless of the growth temperature (Fig. 1d, e). In contrast, ∆mptA formed colonies that are comparable in size to the WT colonies when grown on Middlebrook 7H10 at either temperature (Fig. 1d, e). These observations suggested that the growth defect of ∆mptA is medium-dependent. We complemented the mutant with an integrative vector carrying a native promoter region fused with either WT mptA gene or catalytically inactive D129A mptA (see Materials and Methods). The vector was integrated into the mycobacteriophage L5 attB site on the chromosome of ∆mptA. Aspartic acid residues in the predicted periplasmic loop between the third and fourth transmembrane domains are suggested to be critical for enzymatic activity13. We mutated one of the aspartic acid residues and found that this mutant failed to restore LAM synthesis (Fig. 1c). The lack of phenotypic complementation is not due to the lack of protein production as both WT and D129A mutant MptA were present at comparable levels (Fig. 1b). The levels of MptA production were substantially higher than the endogenous level despite our attempt to use the putative native promoter region to express the gene (Fig. 1b). Interestingly, the WT MptA restored LAM production, but LM failed to accumulate (Fig. 1c), possibly due to the overexpression of mptA (see discussion). Nevertheless, the small colony defect of the mutant grown on LB was restored in the complemented strain, ∆mptA L5::mptA (WT), but not with ∆mptA L5::mptA (D129A) (Fig. 1d, e), indicating that the restoration of LAM synthesis is sufficient for the restoration of the colony morphology defect. To examine the growth defect further, we conducted live/dead staining of M. smegmatis micro-colonies grown in LB in a glass-bottomed 96-well plate. WT and ∆mptA strains were stained with SYTO9 and propidium iodide such that live cells stained green and dead cells stained red. We found that WT micro-colonies had very few propidium iodide-positive dead cells (Fig. 1f). In contrast, ∆mptA micro-colonies revealed many propidium iodide-stained cells, indicating ∆mptA is more prone to cell death when grown as micro-colonies in LB broth (Fig. 1f). Collectively these results suggest that MptA and its biosynthetic product LAM contribute to cell survival during aggregated growth conditions where LB is used as the medium.
∆mptAcannot maintain cell shape and lyses in pellicle growth
We examined pellicle growth as it is an experimentally more tractable and scalable biofilm growth model than colony growth. We compared growth of the WT, ∆mptA, and complemented strains in M63 broth as LB did not support robust pellicle growth of M. smegmatis23. Because we observed cell death in LB-grown micro-colonies, we examined if ∆mptA lyses under pellicle growth. The pellicle of ∆mptA and its complemented strains showed typical rugose appearance, which was similar to the appearance of the WT pellicle (Supplementary Fig. S1a). However, ∆mptA accumulated significantly higher levels of proteins in their culture medium than the WT (Supplementary Fig. S1b). Mpa is a cytoplasmic protein, which is normally detected at a low level in the spent medium but was detected at a substantially higher level in the spent medium of ∆mptA (Supplementary Fig. S1b). These mutant phenotypes were restored by expressing the WT but not D129A mutant mptA (Supplementary Fig. S1b). Consistent with potential cell lysis, microscopic examination revealed morphological defects of ∆mptA (Supplementary Fig. S1c). We quantified morphological defects by measuring the cell width profile across the normalized cell length (Supplementary Fig. S1c) and determining the distribution of maximum cell widths for each strain (Supplementary Fig. S1d). These quantitative analyses revealed that ∆mptA shows statistically significant morphological defects, which were restored by WT MptA, but not by D129A mutant MptA (Supplementary Fig. S1c, d). Additionally, we quantified the cell length distributions for WT, ∆mptA, and complemented strains and found no significant difference in length between WT and ∆mptA cells grown as pellicles in M63 (Supplementary Fig. S1e). Both complemented strains exhibited slight but statistically significant decreases in cell length compared to WT cells (Supplementary Fig. S1e).
Medium-dependent growth defect of ∆mptAin planktonic culture
The above results suggest that ∆mptA and ∆mptA L5::mptA (D129A) struggle to maintain cell shape and lyse in aggregated growth. While our previous study showed that mptA KD cells display no defect when growing planktonically in Middlebrook 7H922, we wondered if planktonically grown cells also show similar morphological defects in a medium-dependent manner. When we grew ∆mptA in Middlebrook 7H9 broth, they grew similarly to the WT, as previously observed for mptA KD cells (Fig. 2a–c). The cell morphology of ∆mptA was also comparable to WT, with only a minor increase in cell widths and a similarly minor decrease in cell lengths (Fig. 2d–f). In contrast, when ∆mptA was grown in LB broth, there was a growth defect, and its morphology was aberrant, as observed in pellicle growth (Fig. 2g–l). The statistically significant difference in doubling time between WT and ∆mptA grown in LB (Fig. 2h) should not be influenced by the morphological defects of ∆mptA since doubling time is the rate of growth calculated from the change in optical density of each individual bacterial strain. Nevertheless, we further confirmed that the growth defect in LB measured by optical density at 24 h post inoculation also corresponded to a significant difference in CFU/mL between WT and ∆mptA (Fig. 2i), further confirming that planktonic growth of ∆mptA is defective in LB. The growth and morphological defects of ∆mptA were restored by complementation with WT mptA but not with D129A mutant mptA (Fig. 2g–k). In LB growth medium, we did not observe any differences in cell length between WT and ∆mptA (Fig. 2l). We finally tested osmo-protective LB, in which the medium was supplemented with sorbitol, a non-metabolizable osmolyte. Sorbitol was unable to support the growth of M. smegmatis in M9 Minimal Medium as a sole carbon source (Supplementary Fig. S2a). When supplemented in LB at 500 mM, sorbitol suppressed the morphological defects (Supplementary Fig. S2b, c), implying that cell shape deformation is dependent on the osmolarity of the medium. These data together suggest that the growth of ∆mptA is conditionally defective in a medium-dependent manner and is not specific to aggregated growth.
∆mptAis hypersensitive to beta-lactam antibiotics
The suppression of the morphological defect when ∆mptA cells were grown in high-osmolarity growth media (see Supplementary Fig. S2b, c) suggests that the turgor pressure is the force responsible for deforming the ∆mptA cell envelope and that the load-bearing function of the cell wall is compromised in the absence of LM and LAM. Previous work showed that mptC overexpression (OE), which stunts lipoglycan size, led to increased sensitivity to cell envelope-targeting antibiotics16,22, further suggesting that diminutive lipoglycans may compromise envelope integrity. Since ∆mptA produces even less developed lipoglycans than mptC OE, we tested whether this strain is similarly sensitive to cell envelope-targeting antibiotics. We determined the MIC of seven different drugs for WT and ∆mptA M. smegmatis grown in Middlebrook 7H9. We found that ∆mptA is over 40 times more sensitive to ampicillin+sulbactam and 8 times more sensitive to meropenem+sulbactam than WT (Supplementary Table S1). Increased sensitivity of ∆mptA to the non-beta-lactam drugs was minor in comparison, indicating a specific sensitivity towards drugs targeting peptidoglycan crosslinking in cells deficient in LM and LAM. Sulbactam was added to inhibit the action of beta-lactamase on beta-lactams, but was also added to the non-beta-lactam antibiotic treatments in order to test all drugs under the same condition. Since the morphological defects were detected in LB broth, we suspected that the increased sensitivities of ∆mptA to beta-lactams may become even more pronounced in this medium. Indeed, MICs of ampicillin+sulbactam and meropenem+sulbactum for WT became 85 and 128 times that of ∆mptA, respectively, demonstrating enhanced beta-lactam sensitivity of ∆mptA in LB compared to Middlebrook 7H9 (Supplementary Table S2). Furthermore, supplementing sorbitol reduced the vulnerabilities of ∆mptA to these drugs in LB medium (Supplementary Table S2). The increased beta-lactam sensitivities were partially restored in ∆mptA complemented with the WT but not with D129A mutant mptA (Supplementary Table S3). These observations reiterate the loadbearing defects of ∆mptA cell wall that would make the mutant vulnerable to drugs targeting peptidoglycan crosslinking.
LAM-deficient cells fail to maintain cell shape
Our results suggest that the absence of LM and LAM weakens the structural integrity of the peptidoglycan cell wall, and makes the cells vulnerable to turgor pressure, resulting in characteristic “blebbing” of the cell, observed in other cell wall-defective mutants24–26. The complemented strain, ∆mptA L5::mptA (WT), restored LAM but not LM, implying that LM does not contribute to the morphological defects (see Fig. 1). To provide further insights on the specific structural component of LM/LAM that is essential for maintaining cell shape, we used a collection of other M. smegmatis mutants known to produce altered lipoglycans. We first confirmed the expected lipoglycan profiles of each strain under our experimental conditions. Using planktonic LB culture, we harvested log phase cells, extracted their LM and LAM, and visualized LM and LAM by SDS-PAGE (Fig. 3a). ∆mptC produces LAM but does not accumulate LM, as previously demonstrated16. Having a similar LM/LAM phenotype to ∆mptA L5::mptA (WT), ∆mptC maintained rod shape without any morphological defects (Fig. 3b, c). These results indicate that LM is not critical for maintaining envelope integrity and suggest that LAM is an important lipoglycan for envelope integrity. To further investigate, we analyzed the cell width of an mptC OE strain previously shown to produce LM and LAM with both dwarfed mannan and arabinan domains16. We reasoned that this strain should display an intermediate morphology defect since it produces a LAM molecule with a small arabinan domain16. As expected, mptC OE had a significant blebbing defect, but with only 36% of cells in contrast to 67% of ∆mptA cells (Fig. 3b, c, compared with Fig. 2j, k). These results suggest that the presence and correct size of the arabinan domain are both required for optimal cell wall integrity. To test this more directly, we initially attempted to delete the gene encoding the key arabinosyltransferase EmbC. Whereas embC has been deleted in previous studies27,28, we were unable to delete the gene in M. smegmatis for unknown reasons (see Methods). We therefore knocked down the expression of embC by anhydrotetracycline (ATC)-inducible CRISPRi. Being consistent with the phenotype of embC deletion mutant reported in previous studies27,28, embC knockdown resulted in a reduced amount of LAM upon ATC addition (Fig. 3a). When this strain was grown planktonically in LB with ATC, 50% of cells displayed a blebbed morphology like that seen for ∆mptA and mptC OE strains. The morphological defects were observed only when ATC was added. These data demonstrate the importance of the arabinan domain of LAM in maintaining cell shape (Fig. 3b, c). Analysis of cell lengths revealed no substantial defects, though the mutants were all slightly shorter than WT on average (Fig. 3d).
Envelope deformations are associated with new poles and septa
We noticed that many of the cell wall deformations were polar, potentially indicating that the cell wall defect is associated with elongation or division. Due to mycobacteria’s asymmetric growth, we can determine whether the blebs are associated with the old pole (cell elongation) or the new pole (septation and division). To determine cell polarity, we incubated cells with a fluorescent d-amino acid (FDAA) analog, called RADA, which is actively incorporated into growing or remodeling cell walls by endogenous cross-linking enzymes29. Bright and dim RADA labeling of cell poles correlates with old and new poles, respectively24. As expected, WT and ∆mptA cells grown in LB planktonic culture were labeled asymmetrically at the cell poles, with one pole labeling brighter and extending farther into the sidewall, representing the old pole, and one pole labeling dimmer, representing the new pole. We then aligned each non-septated blebbed ∆mptA cell according to old/new pole determined by its RADA labeling and plotted the cell width profiles. The majority of maximum cell widths for non-septated blebbed cells associated with new poles, though some blebs were associated with the midcell (Supplementary Fig. S3a). Intriguingly, ∆mptA cells also displayed higher RADA labeling at the sidewall, particularly at deformed regions of the cell envelope on the new pole half of the cell, indicating increased peptidoglycan remodeling along the sections of the cell envelope that are not actively growing (Supplementary Fig. S3b, c). The sidewall RADA labeling was not observed once ∆mptA was complemented with the expression of WT mptA but was observed when complemented with D129A mutant mptA (Supplementary Fig. S3b, c). The increased FDAA labeling at the regions of envelope deformations suggests that intense remodeling was induced to repair damaged or weak peptidoglycan cell wall. Since RADA labels septa, we also noticed that cell envelope deformations in septated ∆mptA cells were often associated with septa, further suggesting a link between division and LAM function (Supplementary Fig. S3d). These data suggest that LAM is specifically important for peptidoglycan integrity during or immediately after septation and daughter cell separation and not the active elongation of old poles.
PonA1 restores envelope integrity in LM/LAM-deficient cells
The new pole/septal location of cell envelope deformation suggests LAM may be necessary for controlling septal peptidoglycan hydrolase activity. Septal hydrolases must be able to cut the peptidoglycan connecting two daughter cells to achieve cell separation without destroying the peptidoglycan associated directly with each daughter cell’s inner membrane. This implies that some periplasmic factor spatially restricts the activity of septal hydrolases to avoid indiscriminate cell wall damage around the septum/new pole, and LAM may be involved in such spatial regulations of septal hydrolases. The predominant septal hydrolase in M. smegmatis is RipA, which forms a complex with another hydrolase RpfB. The synergistic activity of this septal hydrolase complex is directly inhibited by the penicillin-binding protein PonA1 through a RipA-binding motif on PonA1’s C-terminus (Fig. 4a)25,30–32. To test whether RipA/RpfB complex inhibition by PonA1 could prevent envelope blebbing, we constitutively overexpressed ponA1 in ∆mptA, and confirmed the overexpression by Bocillin FL Penicillin labeling (Fig. 4b). Since mptA is deleted, we did not expect that LM/LAM biosynthesis would be restored in ∆mptA L5::ponA1. We confirmed that only a small LM intermediate was detectable in ∆mptA L5::ponA1 (Fig. 4c). Strikingly, ∆mptA L5::ponA1 maintained rod shape cell morphology (Fig. 4d–f) and restored normal RADA labeling (Fig. 4g), indicating that the expression of PonA1 successfully rescued the peptidoglycan defect in the LM/LAM deficient ∆mptA mutant. To directly determine whether the cell wall defect of ∆mptA is dependent on RipA and its downstream operon partner RipB, an ATC-inducible ripAB CRISPRi KD construct was integrated into the L5 site of the ∆mptA strain (∆mptA L5::ripAB KD) and the WT strain (WT L5::ripAB KD). When ATC was not added to the culture medium, each uninduced strain mimicked the cell morphology phenotype of their parental strains: ∆mptA L5::ripAB KD blebbed and WT L5::ripAB KD formed healthy rod-shaped cells (Fig. 4h). Consistent with published results31,32, induction of ripAB knockdown via addition of ATC resulted in cell elongation and ectopic pole formation/branching in both genetic backgrounds, indicative of failed division in the absence of the key septal hydrolase, while the cell width characteristics of each strain remained similar to uninduced conditions (Fig. 4h). Notably, healthy cell width characteristics and peptidoglycan remodeling were not restored in ∆mptA L5::ripAB KD upon knockdown of the key septal hydrolase RipA, indicating that the cell wall defect of ∆mptA is not due to the dysregulation of RipA.
Cells producing a large LAM are defective in cell separation
Since dwarfed LAM weakens cell wall near the septum, a larger LAM may have the opposite effect of preventing the localized weakening of cell wall, like the ripA-deficient mutant, which cannot separate the two daughter cells and becomes multi-septated. We previously demonstrated that overexpression of mptA results in larger LAM molecules16. To determine any potential impacts producing a larger LAM molecule has on the cell wall or cell division, we transformed the WT strain with the acetamide-inducible mptA expression vector as before16. Acetamide-inducible promoter was leaky and MptA was produced in the transformant without acetamide addition at a level higher than the endogenous WT level (Fig. 5a). Upon incubation with acetamide for 8 h, there was a robust overproduction of MptA (Fig. 5a), and the apparent molecular weight of LAM became larger (Fig. 5b). We have previously shown that both mannan and arabinan part of LAM becomes larger by the acetamide-induced MptA overproduction16. While larger LAM did not affect the cell width (Fig. 5c), there were some cells that were quite long, although this slight increase in cell length at the population level was not significant compared to the vector control (Fig. 5d). After incubation with acetamide, the cells were labeled with the FDAA peptidoglycan probe HADA, which indicated a hyperseptation phenotype in a subset of cells (Fig. 5e). We quantified the percentage of septated and multiseptated cells in the mptA overexpression strains (with or without acetamide addition) and compared with empty vector control, WT, ∆mptA, and ∆mptC to determine the prevalence of this cell division defect at the population level (Fig. 5f). While only 20% of WT and ∆mptA cells were septated of which 2% were multiseptated, 46% of mptA OE cells were septated of which 29% were multiseptated upon induction of gene expression by acetamide. Without acetamide-induced mptA overexpression, 0% of cells were multi-septated, demonstrating that strong overexpression of mptA inhibits the successful resolution of septation events. Since LM does not accumulate in the mptA OE strain (Fig. 5b), the division defect could either result from the lack of LM or the production of larger LAM. To test this, we observed the level of septation in the ∆mptC strain, which also does not accumulate LM but does not produce a large LAM molecule (see Fig. 3a). 24% of ∆mptC cells had a single septum and none were multiseptated, indicating that the lack of LM in this strain did not lead to a drastic increase in the number of septa over WT. Together, these results indicate that biosynthesis of an abnormally large LAM, not the lack of LM accumulation, correlates with the division defect.
A previous study found that in M. tuberculosis, the protease MarP proteolytically activates the septal peptidoglycan hydrolase RipA in response to low pH33. MarP is conserved in M. smegmatis. We therefore reasoned that acidic growth conditions, which increase the activity of RipA, may increase septal hydrolysis enough to resolve the multiseptation effect associated with oversized LAM in mptA OE. To test this, we grew WT and mptA OE in LB adjusted to pH 5.5 and compared the level of septation with that observed when cells were grown in standard LB (pH = 7) (Fig. 5g). The acidic growth condition nullified the hyperseptation phenotype, suggesting that increased RipA activity may rescue this division defect. While increased RipA activity may help cells with large LAM to divide, LAM’s function does not appear to be directly involved in modulating RipA activity per se as we observed that knocking down this hydrolase did not rescue cells deficient in LAM (see Fig. 4h). If this is indeed the case, then the division defect observed in mptA OE may be phenotypically distinct from that of cells deficient in RipA. In support of this, we found that while both mptA OE and induced WT L5::ripAB KD have a multiseptation defect, the spacing between septa is markedly different between the two strains (Fig. 5h). Knocking down ripAB results in consistent interseptal distances, indicative of regular cell wall elongation followed by failed cell separation, while mptA OE displays much less consistent and shorter interseptal distances. Shorter interseptal distances in mptA OE correlated with shorter cell length (Fig. 5i). Multiseptated ripAB KD cells are at least ~9 µm long while mptA OE cells that are as short as ~5 µm can become multiseptated. These data are consistent with the possibility that mptA OE is defective in post-septation cell elongation or prone to uncontrolled hyperseptation. It is worth noting that some septa were so close together in the mptA OE strain that they may be one “spiral” shaped septum resulting from an improperly condensed Z-ring. Overall, these data support a model in which the size of LAM impacts cell envelope structure at sites of division, leading to the success or failure of cell division and/or subsequent elongation.
mptAknockdown recapitulates cell shape defects inM. tuberculosis
All genome-wide mutant screening studies predict that mptA is essential in M. tuberculosis34–36. A recent genome-wide CRISPRi KD study also supported the same conclusion, and further indicated that mptA KD results in significantly higher sensitivity to vancomycin, a drug targeting cell wall biosynthesis37. We created an mptA CRISPRi knockdown construct, and the strain transformed with the construct was tested for the predicted growth defect. As shown in Fig. 6a, the mptA KD strain showed a growth delay after the second subculturing with ATC. We determined the reduced levels of MptA protein at the end of the second subculture by immunoblotting using anti-MptA antibody (Fig. 6b). Furthermore, the levels of LM and LAM were reduced (Fig. 6c), and the cell morphology became aberrant (Fig. 6d). Taken together, these data recapitulate the phenotype of M. smegmatis ∆mptA and support that mptA is an essential enzyme in M. tuberculosis.
Overexpression ofmptCinduces cell shape defects inM. tuberculosis
Since overexpression of mptC led to morphological defects in M. smegmatis (see Fig. 3), we next overexpressed mptC to further examine the role of lipoglycans in M. tuberculosis cell shape maintenance. We have previously overexpressed mptC in M. tuberculosis and showed that the mutant produces a reduced amount of smaller LAM although the apparent size changes were not as drastic as what were observed in M. smegmatis16 (see Supplementary Fig. S4e). mptC OE also makes the M. tuberculosis mutant more sensitive to beta-lactams22, suggesting the potential impact of LM/LAM on peptidoglycan integrity. Since we previously showed that a D45A mutation makes M. smegmatis MptC catalytically inactive16, we introduced an equivalent D46A mutation in M. tuberculosis MptC and overexpressed mptC encoding either the WT or D46A mutant versions in M. tuberculosis. The overexpression of WT mptC, but not D46A mptC, induced morphological defects in M. tuberculosis (Supplementary Fig. S4a–d). Similar to mptC OE in M. smegmatis, maximum cell width became substantially larger when WT mptC is overexpressed in M. tuberculosis (Supplementary Fig. S4b). Cell length was not affected (Supplementary Fig. S4c). D46A MptC did not induce any morphological defects. Immunoblotting confirmed that both WT MptC and D46A mutant MptC were overexpressed at comparable levels relative to the endogenous level in WT M. tuberculosis (Supplementary Fig. S4d). Despite the overexpression, D46A MptC had no effect on LM/LAM profile, in contrast to WT MptC overexpression (Supplementary Fig. S4e), being consistent with the mutant being catalytically inactive. Taken together, these results further support an evolutionarily conserved role of LAM in mycobacterial cell division.
Discussion
In 1975, Norman Shaw proposed to use the term lipoglycan for Gram-positive macroamphiphiles that are structurally and functionally distinct from Gram-negative lipopolysaccharides38. Lipoglycans are widely found in Gram-positive bacteria, including Actinobacteria, that do not produce lipoteichoic acids (LTAs). This intriguing observation led to a speculation that LTAs and lipoglycans fulfill functionally equivalent roles39–41, but the analogy has been purely speculative. In the current study, we showed that the mycobacterial lipoglycan, LAM, regulates septation and division through modulating cell wall integrity. A similar role in septation and cell division has been ascribed to LTAs in several Gram-positive bacteria42–45. In particular, S. aureus LTA biosynthesis proteins localize to division sites and interact directly with multiple divisome and cell wall synthesis proteins46, and S. aureus mutants lacking LTA display aberrant septation and division as well as shape defects associated with cell lysis44,47. Furthermore, excessively long LTAs result in defective cell division, leading to cell “chaining” phenotypes48. These phenotypes are strikingly similar to what we observed in M. smegmatis LAM mutants, suggesting important roles these lipopolymers may play during cell division. Since LAM is not present in many other Gram-positive bacteria that do not produce LTAs, it remains to be tested if other types of lipoglycans play similar roles in other bacteria.
Our results corroborate and unify previous findings suggesting the medium-dependent importance of LAM in mycobacterial growth and envelope integrity. The early report of ∆mptA’s small colony phenotype on LB was the first indication that LM and/or LAM were important for mycobacterial viability13. In contrast, a later report showed that an mptA conditional knockdown strain grew normally in Middlebrook 7H9 growth medium22. Our current study verified the cause of the contrasting observations in the previous studies and demonstrated the importance of culture medium in determining the fitness of ∆mptA. The role LAM plays in growth is further supported by the observation of a similar small colony phenotype on complex solid medium for an M. smegmatis lpqW deletion mutant. LpqW acts at the branch point in PIM/LM/LAM biosynthetic pathway to shunt AcPIM4 more towards LM/LAM biosynthesis than AcPIM6 biosynthesis49. Presumably due to the redirection of AcPIM4 to AcPIM6 synthesis, ∆lpqW failed to accumulate LM and LAM49. ∆lpqW accumulates mutations in pimE, preventing the conversion of AcPIM4 to AcPIM6, when grown on LB but not on Middlebrook 7H10, resulting in restored colony size and biosynthesis of LM and LAM50. Additional studies are needed to identify what makes ∆mptA and ∆lpqW struggle to grow on LB. It is also notable that WT MIC values for cell wall targeting drugs vary considerably between LB and Middlebrook media, which may reflect significant medium-dependent differences in cell envelope architecture and dynamics that may dictate the importance of mycobacterial lipoglycans.
One clue as to how LM and LAM may be important for growth came from the observation that mptC OE truncated LM and LAM and concomitantly increased sensitivity to cell wall-targeting antibiotics22. This observation suggested that lipoglycan deficiency may compromise the mycobacterial cell wall in some way. In the current study, we demonstrated that peptidoglycan remodeling, and its load-bearing and shape maintenance functions are compromised in the absence of LM and LAM. Furthermore, we demonstrated that LM/LAM-deficient cells are specifically sensitive to inhibition of cell wall crosslinking, and that cell shape defects and de-localized peptidoglycan remodeling are subcellularly localized to regions associated with recent division and not general elongation in LM/LAM-deficient cells. By testing the cell morphology characteristics of five distinct LM/LAM biosynthetic mutants, we determined that full-sized LAM, and not LM, is important for maintaining envelope integrity. A recent study indicated that the α1-6 mannan backbone of LM/LAM carries 13-18 mannose residues51. Using CHARMM-GUI Glycan Modeler, the chain of 13 α1-6-linked mannoses is predicted to form a 4.2 nm helix52,53. It should be noted that intermolecular interactions with other periplasmic structures, such as proteins, could affect the coiling of the α1-6-linked helical mannan of LM and LAM and thus change its length to some degree. Nevertheless, given the predicted height of the periplasmic space being 14-17 nm54, the mannan backbone part of LM/LAM is probably not sufficient to span the periplasmic space and reach the peptidoglycan layer. However, ~23 residues of α1-5-linked arabinose, found as a branch in the arabinan part of LAM51, can extend LAM by 9.8 nm, which makes it long enough to reach the peptidoglycan layer. Multiple branches of these arabinan chains increase the surface area/coverage of the lipoglycan structure precisely where the molecule may interact with the cell wall or cell wall-acting proteins. Our data are consistent with defects in peptidoglycan integrity, but the defects may be present in other parts of the cell envelope. Although it is beyond the scope of the current study, detailed structural analyses are needed to determine the precise structural defects in the cell envelope of ∆mptA.
Cells lacking sufficient cell wall hydrolase activity fail to fully divide, resulting in a multi-septation phenotype32. We initially hypothesized that LAM could be modulating septal hydrolase activity such that in the absence of LAM, hydrolase activity becomes too active and when LAM is too big, hydrolase activity is impaired. However, we determined that the key septal hydrolase, RipA, was not responsible for the cell shape defect observed in LAM-deficient cells, as knocking down ripAB expression in the ∆mptA background did not relieve cell shape defects. The compounded phenotypes of mptA deletion and ripAB knockdown demonstrate that the cell wall defects of LAM-deficient cells near septa and new poles are independent of RipA-mediated cell separation. Additionally, we showed that the multiseptation defect in large LAM-producing cells was qualitatively different from the multiseptation defect in ripAB KD cells. The less regular interseptal distances of the mptA OE strain suggest that LAM may be involved in proper septal placement or cell elongation immediately after septal placement.
Intriguingly, ponA1 overexpression rescued ∆mptA even though we showed that RipA is not the cause of cell shape defects in ∆mptA. Apart from RipA, PonA1 is known to physically interact with another divisome protein LamA, which is involved in maintaining division asymmetry and drug resistance55. PonA1 also interacts with the potential scaffold protein MSMEG_1285 (Rv0613c), which is known to interact physically with additional cell envelope proteins56. Since PonA1 is involved in both division and elongation, which are processes likely driven by large multi-protein divisome and elongasome complexes, PonA1 is likely to interact with additional proteins involved in growth and division (see reviews57,58). These additional interactions and/or its own peptidoglycan biosynthetic activities may explain the RipA-independent rescue of ∆mptA with PonA1. Precise molecular mechanisms by which LAM governs the functions of mycobacterial divisome in a RipA-independent manner is an important topic of future research.
The role of LM remains unknown. The LM precursor accumulating in ∆mptA disappeared when the mutant was complemented by mptA, and this effect was not dependent on the catalytic activity of MptA as it disappeared even in ∆mptA complemented with catalytically inactive MptA (see Fig. 1). When we overexpressed MptA in the WT background, even a leaky expression in the absence of acetamide was enough to make mature LM disappear (see Fig. 5). We do not know the molecular mechanism of these phenomena, but we previously proposed that the balance of MptA and MptC is important for the mannan chain termination and LM accumulation16. The action of MptC to add α1-2 mannose side chain may be critical for LM accumulation, and MptA, when expressed at a high level, may impose a dominant negative effect on MptC and block its action, resulting in no LM production. Since LM precursor was absent when catalytically dead MptA was produced in ∆mptA, LM precursor accumulation may also be dependent on MptC and the dominant negative action of MptA on MptC may not require its catalytic activity. Alternatively, it is possible that MptA imposes a dominant negative effect on the mannosyltransferase that elongates PIM4 to the LM precursor. These mannosyltransferases likely function in a finely coordinated manner to synthesize LM and LAM, requiring balanced regulation of one another. Importantly, the growth and morphological defects of ∆mptA were restored by complementation with WT mptA even though we could not restore the LM level in these complemented strains, indicating that LM is not the culprit of these phenotypes we focused on in the current study.
We reproduced similar morphological defects in M. tuberculosis by either knocking down mptA or overexpressing mptC. The morphological defects provide support for the observed growth delay of M. tuberculosis upon CRISPRi depletion of mptA. Furthermore, our data corroborate previous genome-wide predictions that mptA is an essential gene in M. tuberculosis34–37. Nevertheless, our studies on M. tuberculosis are limited and further verifications are necessary to clarify the role of lipoglycans in M. tuberculosis and other pathogenic mycobacteria. The conditional nature of the growth and morphological defects of M. smegmatis ∆mptA is intriguing, and it remains possible that the growth defects of the M. tuberculosis mutants are also conditional. The molecular mechanism of cell envelope maintenance and the role of LAM that potentially makes mptA essential in M. tuberculosis remain to be explored.
Methods
Growth
For planktonic growth of M. smegmatis mc2155, cells were grown in Middlebrook 7H9 supplemented with 15 mM NaCl, 0.2% (w/v) glucose, and 0.05% (v/v) Tween-80 or LB supplemented with 0.05% (v/v) Tween-80 and incubated at 37 °C and 130 rpm until mid-log phase (OD600 = 0.5–1.0). For pellicle biofilm growth of M. smegmatis, 20 µL planktonic stationary phase culture was diluted 1:100 into 2 mL M63 medium in a 12-well plate and incubated for 3–5 days at 37 °C without shaking. Spent culture medium was filtered through a 0.22 µm filter to remove residual cells. Example macro-images of pellicle morphology were photographed with an iPhone 12 camera (Apple). For colony growth, serial dilutions of planktonic culture were spread evenly over LB or Middlebrook 7H10 (supplemented with 15 mM NaCl and 0.2% (w/v) glucose) solid agar medium and incubated at 30 °C or 37 °C for 3–4 days. Colonies were photographed using Amersham ImageQuant 800 (Cytiva) and colony area was determined using ImageJ software59. Example macro-images of colony size and morphology were photographed with an XT-1 mirrorless camera (Fujifilm). M. tuberculosis mc26230 (a ∆RD1/∆panCD attenuated strain60 was grown in Middlebrook 7H9 supplemented with Middlebrook OADC supplement, 25 µg/mL d-pantothenic acid, and 0.05% (v/v) Tween-80 at 37 °C with shaking.
Construction of ∆mptA and complemented strains
To generate an unmarked mptA deletion mutant, genomic regions upstream and downstream of MSMEG_4241 (mptA) were amplified by PCR using primers (5’- GACAGGACTCTAGCCAAAGAACATCGGTCCGGTGTACG −3’ and 5’- CGGCTCGCCGTCGTGGCCTAGGTGTGGACTGTCGAGCC −3’ for the upstream region and 5’- TAGGCCACGACGGCGAGC −3’ and 5’- GCTGTCAAACCTGCCAACTTATCACGCTGGTGGAAGTGAT −3’ for the downstream region) and assembled using NEBuilder HiFi DNA Assembly cloning kit (NEB) into pCOM161. This construct, designated pMUM241, was electroporated into WT M. smegmatis and clones that had incorporated the vector into the genome via single homologous recombination event were selected for on Middlebrook 7H10 plates containing 100 µg/mL hygromycin. A “single cross-over” mutant was isolated and grown to an OD of 1 in the absence of hygromycin to allow a second recombination event to complete the gene deletion and excise the vector backbone. The “double cross-over” strain was selected for on Middlebrook 7H10 plates containing 5% sucrose. Candidate clones were confirmed to be sensitive to hygromycin and resistant to sucrose indicating the loss of the vector backbone. The absence of MSMEG_4241 (mptA) was confirmed by PCR with primers (5’- AGTACCTGCGCGAACGTC −3’ and 5’- TGAGCAGTTCGAAGGTCAGG −3’) using the genomic DNA of the mutant as a template. To generate complemented strains of ∆mptA, we first created an expression vector of mptA driven by a native promoter. The mptA gene (MSMEG_4241) is in frame with and directly downstream of MSMEG_4240, a putative geranylgeranyl pyrophosphate synthetase gene, suggesting that these two genes form an operon. Ribosomal profiling of this locus also supports co-transcription of these two genes62. Thus, in an attempt to complement expression of mptA under control of its native promoter, we cloned the 153 bp sequence upstream of MSMEG_4240 by PCR using 5’- TCCAGCTGCAGAATTCGACCGAAACGTGACGGCGA −3’ and 5’- GCTCAGCGCCCGCCCCTTTC −3’ as primers. The full mptA (MSMEG_4241) sequence was PCR-amplified by 5’- AAGGGGCGGGCGCTGAGCATGACACCGACGGAAACCCA −3’ and 5’- ACTACGTCGACATCGATATCATTGACGGCTCGCCGTCG −3’. Both of these PCR fragments were ligated via HiFi cloning into pMV306 digested with HindIII, resulting in pMUM364. To make an expression vector to produce a catalytically inactive D129A mutant of MptA, site-directed mutagenesis was performed using Platinum SuperFi DNA polymerase (Invitrogen) according to kit instructions. The sense and anti-sense primers, 5’- CAGCCGTGCCACGTACTCCTACCTGG −3’ and 5’- GAGTACGTGGCACGGCTGAACAGCGG −3’, were used to mutagenize the aspartic acid residue within the catalytic loop between the third and fourth transmembrane domains13. The expression vectors were electroporated and integrated into the mycobacteriophage L5 attachment (attB) site. Transformants were selected for on Middlebrook 7H10 plates containing 50 µg/mL kanamycin.
Protein analysis by SDS-PAGE and immunoblotting
Cell lysates were prepared by bead-beating as described previously63. Cell lysates and culture filtrates were separated by SDS-PAGE (10% or 12% gel). For culture filtrate, an equal volume of each sample was loaded. For cell lysates, an equal amount of protein was loaded to each lane. For immunoblotting, the gel was transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad) in a transfer buffer (25 mM Tris-HCl (pH 8.3), 192 mM glycine, 0.1% SDS (w/v)) at 14 V for overnight. The membrane was blocked in a blocking buffer (5% skim milk in PBS + 0.05% Tween-20 (PBST)) for 1–2 h at room temperature probed with rabbit anti-M. smegmatis Mpa (1:2000 dilution), rabbit anti-M. smegmatis MptA (1:1000 dilution)16, rabbit anti-M. tuberculosis MptA (1:1000 dilution) or anti-M. tuberculosis MptC (1:1000 dilution)22 in the blocking buffer for 1 h at 4 °C, and washed 10 min 3 times in PBST before being incubated with horseradish peroxidase-conjugated anti-rabbit IgG (Cytiva, Cat# NA9340V) diluted 1:2000 in the blocking buffer for 1 h at room temperature. Finally, the membrane was washed 10 min 3 times in PBST and developed with homemade ECL reagent (2.24 mM luminol, 0.43 mM p-coumaric acid, and 0.0036% H2O2 in 100 mM Tris-HCl (pH 9.35)) and imaged the chemiluminescence using either an ImageQuant LAS-4000mini Imaging System or Amhersham ImageQuant 800 (Cytiva). Anti-M. tuberculosis MptA antibody was raised in rabbit against a mixture of two peptides (CSPDRRGVQAATPVVNTP and MTTPSHAPAVDLATAKDC) (Medical and Biological Laboratories, Tokyo, Japan) and affinity-purified using the same peptides.
Lipoglycan extraction and analysis
Pellets from log phase planktonic cultures were harvested and delipidated with chloroform/methanol/water as previously described22,63. Delipidated pellets were resuspended and incubated in phenol/water (1:1) at 55 °C for 2 h to extract LM and LAM. The aqueous phase containing lipoglycan was washed with an equal volume of chloroform. The resulting aqueous phase was then concentrated by vacuum centrifugation and resuspended in water to obtain purified LM and LAM. LM/LAM samples were incubated with 0.1 mg/mL Proteinase K for 1 h at 50 °C to remove residual proteins and separated by SDS-PAGE (15% gel) with a constant 130 V voltage using a Bio-Rad system. Lipoglycans on the separated gel were then stained using the ProQ Emerald 488 glycan staining kit (Life Technologies) and visualized using Amhersham ImageQuant 800 (Cytiva) as previously described11,16.
Live/Dead staining of microcolonies
For microcolony growth, cells from frozen stock were incubated for 48–72 h in liquid LB media supplemented with 0.05% Tween-80 under shaken conditions at 37 °C. The culture was diluted 100x in fresh LB media (without Tween-80) and deposited in the center of a glass-bottomed well in a 96-well plate (MatTek P96G-1.5-5-F). The culture was then grown at 37 °C under static conditions for approximately 48 h. The medium was replaced with fresh LB media supplemented with 0.1% SYTO9 and 0.1% propidium iodide (Invitrogen) and incubated for 1 h. The microcolonies were imaged using a confocal spinning disk unit (Yokogawa CSU-W1), mounted on a Nikon Eclipse Ti2 microscope with a 100x silicone oil immersion objective (N.A. = 1.35), and captured by a Photometrics Prime BSI CMOS camera.
Microscopy and quantification of cell morphology
Log phase cells were dispensed onto an agar pad (1% agar in water) on a slide glass and imaged at 1000x magnification (100x objective lens, N.A. = 1.30) with a Nikon Eclipse E600 fluorescence microscope. Coordinates of cell outlines were obtained by analysis of phase contrast micrographs analyzed with Oufti (version 1)64. These coordinates were then processed using Python (version 2.7.16) and Python package NumPy (version 1.8.0rc1) with an original python script (https://github.com/IanLairdSparks/Sparks_2023)65 to extract cell width profiles and maximum cell width values for each cell. Cell width profiles of individual cells were compiled to obtain population level cell width profiles. Graphs were created using either matplotlib (version1.3.1) operated in Python or ggplot2 (version 3.3.3) operated in R (version 4.0.3). All experiments are repeated at least twice, and representative results are shown.
Determination of MIC
In a 96-well plate, antibiotics were serially diluted 1:2 in wells containing growth medium (Middlebrook 7H9, LB, or LB supplemented with 500 mM sorbitol) containing 50 µg/mL sulbactam and inoculated with M. smegmatis culture to an OD600 of 0.03. The plate was incubated in biological triplicate for 24 h at 37 °C before the addition of resazurin to a final concentration of 0.0015% (w/v). The plate was incubated for an additional 8 h at 37 °C after which the MIC was determined spectroscopically at 570 and 600 nm, as described previously66.
Construction of ∆embC strain
To generate an unmarked embC deletion mutant, genomic regions upstream and downstream of MSMEG_6387 (embC) were amplified by PCR using primers (5’- GACAGGACTCTAGCCAAAGATACCTACTGGCCGCGATG −3’ and 5’- GTCCGGGTACCACGGCGTCAGGGCTTCGATGCTAACGG −3’ for the upstream region and 5’- TGACGCCGTGGTACCCG −3’ and 5’- GCTGTCAAACCTGCCAACTTATGAGCAGGCCGCCGAT −3’ for the downstream region) and assembled via HiFi cloning into pCOM161. This construct, designated pMUM274, was electroporated into WT M. smegmatis and clones that had incorporated the vector into the genome via single homologous recombination event were selected for on Middlebrook 7H10 plates containing 100 µg/mL hygromycin. A “single cross-over” mutant was isolated and grown to an OD of 1 in the absence of hygromycin to allow a second recombination event to complete the gene deletion and excise the vector backbone. The “double cross-over” candidates were selected for on Middlebrook 7H10 plates containing 5% sucrose. These clones were confirmed to be sensitive to hygromycin and resistant to sucrose, indicating the loss of the vector backbone, which can be either a WT revertant or ∆embC. We used four primers to test the mutants: #1, 5’- TGCGGTGTTCGACGATCC −3’, #2, 5’- GGGACCCTGCGTGAGGC −3’; #3, 5’- CCCCGTCATGGAGCAGC −3’; and #4, 5’- GAGGCTCGATGGTATGCGAC −3’. The primer pair #1 and 4 anneals to the sequences outside of the upstream and downstream genome regions present in pMUM274 to test the deletion of embC. The primers #2 and 3 bind to the vector backbone of pMUM274, and when combined with #1 and 4 respectively, they detect single cross-over mutants. Of the 12 candidates we tested, we found no embC deletion mutants. We further tested 6 additional candidates directly by LM/LAM analysis, and all of them showed the WT phenotype.
Construction of embC and ripAB CRISPRi KD strains
ATC-inducible CRISPRi knockdown L5 integration vectors expressing guide RNAs targeting embC and ripAB were obtained from the Mycobacterial Systems Resource67 and electroporated into WT or ∆mptA M. smegmatis. Transformants were selected for on Middlebrook 7H10 plates containing 20 µg/mL kanamycin and knockdown was induced with 50 ng/mL ATC for 8 h (ripAB KD) or 20 h (embC KD).
Bioorthogonal labeling and quantification
To label short-term peptidoglycan remodeling, RADA was added to log phase cells at a concentration of 10 µM and incubated for 15 min at 37 °C. Cells were washed twice with LB and imaged by phase contrast and fluorescence microscopy. To quantify RADA fluorescence, non-septated cells were first outlined in Oufti from phase contrast micrographs. Fluorescence profiles from corresponding fluorescence micrographs were mapped to each cell and oriented from dim pole to bright pole. Cell fluorescence profile data were extracted from Matlab files output by Oufti using Matlab (version R2022b) and analyzed using a custom python script. The highest values for each cell’s fluorescence profile were normalized to 1 and a high-order polynomial regression curve was fitted to the population-level data to produce an average fluorescence profile for each strain. To fully label cell walls and septa, HADA was added to log phase cells at a concentration of 500 µM and incubated for 1 h at 37 °C. Cells were washed twice with LB and imaged by phase contrast and fluorescence microscopy. The number of septa per cell was manually counted. The distances between septa in multiseptated cells were measured using ImageJ. All experiments are repeated at least twice, and representative results are shown.
ponA1 overexpression vector
The WT ponA1 gene (MSMEG_6900) was PCR-amplified from M. smegmatis genomic DNA using two primers (5’- AAAAAAAACATATGAATAACGAAGGGCGCCACTCC −3’ and 5’- TTTTTTATCGATTCACGGAGGCGGCGGG −3’), which contain NdeI and ClaI sites (underlined), respectively. The PCR product was digested with NdeI and ClaI, and ligated into pMUM261, which was digested with the same enzymes. pMUM261 is a variant of pMUM110, an integrative expression vector driven by the weak P766-8G promoter68. Specifically, in pMUM261, the 5’-UTR up to the HindIII site was replaced with 5’- AAGCTTTTTGGTATCATGGGGACCGCAAAGAAGAGGGGCATATG −3’ to remove an NcoI site and introduce an NdeI site at the start codon, and additionally a 54 bp fragment containing multiple restriction enzyme sites (HpaI-ClaI-AflII-NheI-NcoI) located at the downstream of the TetR38 gene was removed by digesting with NcoI and HpaI, blunt-ending, and self-ligating. Because the P766-8G-driven expression of the resultant pMUM303 plasmid was too low to rescue ∆mptA, we then swapped in the promoter region of pMUM100 (a variant of pMUM10668, but carrying the strong P750 promoter) by digesting both with NheI and HindIII and ligating the relevant fragments, resulting in pMUM314, a P750-driven PonA1 expression vector. The plasmid was electroporated and selected with 50 µg/mL streptomycin.
Catalytically inactive M. tuberculosis mptC overexpression vector
We followed a previously described protocol11. Briefly, we used pYAB230, a previously published mptC (Rv2181) overexpression vector16, as a template. The site-directed mutation of D46A was introduced by Platinum Pfx DNA polymerase (Invitrogen), using 5’- CGCCGTATCGCATCGCGATCGACATCTATCAG −3’ and 5’- CTGATAGATGTCGATCGCGATGCGATACGGCG −3’, as sense and anti-sense primers, respectively, resulting in pYAB297. D46A is equivalent of D45A mutation in the M. smegmatis ortholog MSMEG_424716. M. tuberculosis mc26230 was transformed with pYAB230, pYAB297, as well as an empty vector by electroporation, and selected on 7H10 plates supplemented with 100 µg/mL hygromycin.
Bocillin labeling
PonA1 was detected by Bocillin™ FL (Thermo Fisher) as described69. Briefly, cell lysate containing 30 µg protein was incubated with 100 pmol of Bocillin™ FL in a total volume of 7.5 µl for 30 min at 37 °C. The sample was mixed with 2.5 µl of 4x SDS-PAGE loading dye and incubated for 3 min at 98 °C. The entire sample was then analyzed using SDS-PAGE, and PonA1 bound by Bocillin was visualized utilizing the Amhersham ImageQuant 800 (Cytiva).
Acetamide-inducible MptA overexpression
WT M. smegmatis was transfected with either pJAM2 empty vector or pYAB262, a previously published pJAM2-based acetamide-inducible vector to overexpress mptA16. The transformed strains were grown in Middlebrook 7H9 containing 20 µg/mL kanamycin and mptA overexpression was induced with 0.2% acetamide for 8 h.
CRISPRi knockdown of M. tuberculosis mptA
Published protocols were followed with specific modifications37,70. A single-guide RNA (sgRNA) was designed using a web-based tool (https://pebble.rockefeller.edu/tools/sgrna-design/). Two oligonucleotides (5’-GGGAGCTGTAGCCAAATCAACCGCT −3’ and 5’- AAACAGCGGTTGATTTGGCTACAGC −3’) were annealed by heating to 95 °C and then cooling gradually at the rate of −0.1 °C/s to 25 °C. The double-stranded sgRNA was ligated into a BsmBI-digested plasmid backbone (pIRL58) using T4 DNA ligase (New England Biolabs). The successful integration of the sgRNA into the plasmid was confirmed by Sanger sequencing. M. tuberculosis mc26230 was transformed with the plasmid by electroporation, and selected on 7H10 plates supplemented with 50 µg/mL kanamycin. M. tuberculosis mptA KD strain was grown in Middlebrook 7H9 medium with and without 100 ng/mL ATC at 37 °C with shaking until stationary phase (OD600 > 1.5). Cells were then sub-cultured (1:50 dilution, 2° culture) into a fresh medium with and without 100 ng/mL ATC, grown for 12 days until the uninduced culture (no ATC) reached log phase (OD600 between 0.4 and 1.0). Cells were sub-cultured one additional time (1:50 dilution, 3° culture) into Middlebrook 7H9 medium with or without 100 ng/mL ATC and grown for 7 days when the uninduced culture (no ATC) reached log phase again. Cells were imaged immediately prior to the third sub-culturing and at the end of the third sub-culturing. Cell pellets from the last subculture (3° culture) were collected for cell lysate preparation and lipoglycan extraction.
Statistics
We followed standard guidelines to use the student’s T-test to compare the means between two groups or ANOVA to compare the means among three or more groups71. Thus, statistical significance for all pairwise comparisons was determined by one-tailed student’s T-tests, calculated by the “T-Test Calculator for 2 Independent Means” tool (www.socscistatistics.com) and independently confirmed in Excel (Microsoft, version 16.77.1). For comparisons of more than two means, statistical significance was determined by ANOVA and Tukey HSD post-hoc test, calculated by the “One-way ANOVA (Analysis Of Variance) with post-hoc Tukey HSD (Honestly Significant Difference) Test Calculator for comparing multiple treatments” tool (astatsa.com, 2016 Navendu Vasavada) (see Supplementary Dataset 1 for statistical parameters). To compare categorical variables (non-septated cells vs. septated cells) between groups, significance was determined by the chi-square test using the “Chi-Square Calculator” tool (www.socscistatistics.com). To determine the strength of correlation, Pearson correlation analysis was conducted using the “Pearson Correlation Coefficient Calculator” tool (www.socscistatistics.com), followed by a two-tailed student’s T-test using Excel to determine the significance of the correlation.
Strain and plasmid availability
All mutant strains of M. smegmatis and M. tuberculosis as well as plasmids generated in this study are available from the authors upon reasonable request.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Source data
Acknowledgements
This work was supported by NIH (R21AI168791 to YSM and DP2GM146253 to JY). MP was supported by a fellowship from the University of Massachusetts Amherst as part of the Chemistry-Biology Interface Training Program (National Research Service Award T32 GM008515 and GM139789). We thank Dr. Sloan Siegrist (University of Massachusetts Amherst) for sharing her cell wall labeling expertise and reagents, Dr. Keith Derbyshire (Wadsworth Center) for CRISPRi constructs, Dr. Heran Darwin (New York University) for anti-Mpa antibody, and Dr. William Jacobs (Albert Einstein College of Medicine) for M. tuberculosis mc26230 strain. We thank Stevens Bontemps and Claire Kitzmiller for their help with the experiments.
Author contributions
I.L.S. and Y.S.M. contributed to the conception, experimental design, execution of experiments, drafting, and editing of this work; T.K., M.P., J.N., and J.Y. contributed to the experimental design, execution of experiments, and editing of this work.
Peer review
Peer review information
: Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.
Data availability
Source data are provided with this paper. The data shown in tables, dot plots, scatter plots, and line plots in main and Supplementary Figs. are provided in the Source Data file. All original gel/blot images are also available in the Source Data file. Raw image data for Fig. 1f can be accessed through Dryad (10.5061/dryad.1vhhmgr1w)72. All other image data used to generate data in this study are available from GitHub under https://github.com/IanLairdSparks/Sparks_2023. Source data are provided with this paper.
Code availability
Computer code is available from GitHub under https://github.com/IanLairdSparks/Sparks_202365.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-024-46565-5.
References
- 1.Rahlwes KC, Sparks IL, Morita YS. Cell walls and membranes of Actinobacteria. Subcell. Biochem. 2019;92:417–469. doi: 10.1007/978-3-030-18768-2_13. [DOI] [PubMed] [Google Scholar]
- 2.Batt SM, Minnikin DE, Besra GS. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host’s immune system. Biochem J. 2020;477:1983–2006. doi: 10.1042/BCJ20200194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dulberger CL, Rubin EJ, Boutte CC. The mycobacterial cell envelope - a moving target. Nat. Rev. Microbiol. 2020;18:47–59. doi: 10.1038/s41579-019-0273-7. [DOI] [PubMed] [Google Scholar]
- 4.Thanky NR, Young DB, Robertson BD. Unusual features of the cell cycle in mycobacteria: polar-restricted growth and the snapping-model of cell division. Tuberculosis (Edinb.) 2007;87:231–236. doi: 10.1016/j.tube.2006.10.004. [DOI] [PubMed] [Google Scholar]
- 5.Aldridge BB, et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science. 2012;335:100–104. doi: 10.1126/science.1216166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Santi I, Dhar N, Bousbaine D, Wakamoto Y, McKinney JD. Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria. Nat. Commun. 2013;4:2470. doi: 10.1038/ncomms3470. [DOI] [PubMed] [Google Scholar]
- 7.Botella H, et al. Distinct spatiotemporal dynamics of peptidoglycan synthesis between Mycobacterium smegmatis and Mycobacterium tuberculosis. mBio. 2017;8:e01183-17. doi: 10.1128/mBio.01183-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Korduláková J, et al. Definition of the first mannosylation step in phosphatidylinositol mannoside synthesis. PimA is essential for growth of mycobacteria. J. Biol. Chem. 2002;277:31335–31344. doi: 10.1074/jbc.M204060200. [DOI] [PubMed] [Google Scholar]
- 9.Guerin ME, et al. New insights into the early steps of phosphatidylinositol mannoside biosynthesis in mycobacteria: PimB’ is an essential enzyme of Mycobacterium smegmatis. J. Biol. Chem. 2009;284:25687–25696. doi: 10.1074/jbc.M109.030593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lea-Smith DJ, et al. Analysis of a new mannosyltransferase required for the synthesis of phosphatidylinositol mannosides and lipoarbinomannan reveals two lipomannan pools in Corynebacterineae. J. Biol. Chem. 2008;283:6773–6782. doi: 10.1074/jbc.M707139200. [DOI] [PubMed] [Google Scholar]
- 11.Morita YS, et al. PimE is a polyprenol-phosphate-mannose-dependent mannosyltransferase that transfers the fifth mannose of phosphatidylinositol mannoside in mycobacteria. J. Biol. Chem. 2006;281:25143–25155. doi: 10.1074/jbc.M604214200. [DOI] [PubMed] [Google Scholar]
- 12.Mishra AK, et al. Identification of an alpha(1–>6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue in Mycobacterium tuberculosis. Mol. Microbiol. 2007;65:1503–1517. doi: 10.1111/j.1365-2958.2007.05884.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kaur D, et al. New insights into the biosynthesis of mycobacterial lipomannan arising from deletion of a conserved gene. J. Biol. Chem. 2007;282:27133–27140. doi: 10.1074/jbc.M703389200. [DOI] [PubMed] [Google Scholar]
- 14.Kaur D, et al. Biosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferase. Proc. Natl Acad. Sci. USA. 2006;103:13664–13669. doi: 10.1073/pnas.0603049103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kaur D, et al. Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase. Proc. Natl Acad. Sci. USA. 2008;105:17973–17977. doi: 10.1073/pnas.0807761105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sena CBC, et al. Controlled expression of branch-forming mannosyltransferase is critical for mycobacterial lipoarabinomannan biosynthesis. J. Biol. Chem. 2010;285:13326–13336. doi: 10.1074/jbc.M109.077297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ishikawa E, Mori D, Yamasaki S. Recognition of mycobacterial lipids by immune receptors. Trends Immunol. 2017;38:66–76. doi: 10.1016/j.it.2016.10.009. [DOI] [PubMed] [Google Scholar]
- 18.Vergne I, Gilleron M, Nigou J. Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan. Front Cell Infect. Microbiol. 2014;4:187. doi: 10.3389/fcimb.2014.00187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Franklin, A. et al. The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth. 2023.10.26.563968 Preprint at 10.1101/2023.10.26.5639 (2023). [DOI] [PMC free article] [PubMed]
- 20.Banerjee R, Vats P, Dahale S, Kasibhatla SM, Joshi R. Comparative genomics of cell envelope components in mycobacteria. PLoS One. 2011;6:e19280. doi: 10.1371/journal.pone.0019280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Patterson JH, Waller RF, Jeevarajah D, Billman-Jacobe H, McConville MJ. Mannose metabolism is required for mycobacterial growth. Biochem J. 2003;372:77–86. doi: 10.1042/bj20021700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Fukuda T, et al. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis. mBio. 2013;4:e00472-12. doi: 10.1128/mBio.00472-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Recht J, Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J. Bacteriol. 2001;183:5718–5724. doi: 10.1128/JB.183.19.5718-5724.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Baranowski C, et al. Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape. eLife. 2018;7:e37516. doi: 10.7554/eLife.37516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chao MC, et al. Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria. PLoS Pathog. 2013;9:e1003197. doi: 10.1371/journal.ppat.1003197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kieser KJ, et al. Phosphorylation of the peptidoglycan synthase PonA1 governs the rate of polar elongation in mycobacteria. PLoS Pathog. 2015;11:e1005010. doi: 10.1371/journal.ppat.1005010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Shi L, et al. The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the arabinan in lipoarabinomannan. J. Biol. Chem. 2006;281:19512–19526. doi: 10.1074/jbc.M513846200. [DOI] [PubMed] [Google Scholar]
- 28.Zhang N, et al. The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol. Microbiol. 2003;50:69–76. doi: 10.1046/j.1365-2958.2003.03681.x. [DOI] [PubMed] [Google Scholar]
- 29.García-Heredia A, et al. Peptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria. eLife. 2018;7:e37243. doi: 10.7554/eLife.37243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hett EC, Chao MC, Rubin EJ. Interaction and modulation of two antagonistic cell wall enzymes of mycobacteria. PLoS Pathog. 2010;6:e1001020. doi: 10.1371/journal.ppat.1001020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hett EC, Chao MC, Deng LL, Rubin EJ. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog. 2008;4:e1000001. doi: 10.1371/journal.ppat.1000001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Healy C, Gouzy A, Ehrt S. Peptidoglycan hydrolases RipA and Ami1 are critical for replication and persistence of Mycobacterium tuberculosis in the host. mBio. 2020;11:e03315–e03319. doi: 10.1128/mBio.03315-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Botella H, et al. Mycobacterium tuberculosis protease MarP activates a peptidoglycan hydrolase during acid stress. EMBO J. 2017;36:536–548. doi: 10.15252/embj.201695028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Minato Y, et al. Genomewide assessment of Mycobacterium tuberculosis conditionally essential metabolic pathways. mSystems. 2019;4:e00070-19. doi: 10.1128/mSystems.00070-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.DeJesus MA, et al. Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio. 2017;8:e02133-16. doi: 10.1128/mBio.02133-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Griffin JE, et al. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem. Biol. 2012;19:218–227. doi: 10.1016/j.chembiol.2011.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Bosch B, et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell. 2021;184:4579–4592.e24. doi: 10.1016/j.cell.2021.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Shaw, N. Bacterial glycolipids and glycophospholipids. in Advances in Microbial Physiology (eds. Rose, A. H. & Tempest, D. W.) vol. 12 141–167 (Academic Press, 1975).
- 39.Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 2008;6:276–287. doi: 10.1038/nrmicro1861. [DOI] [PubMed] [Google Scholar]
- 40.Fischer, W. Chapter 10 Lipoteichoic acids and lipoglycans. in New Comprehensive Biochemistry (eds. Ghuysen, J.-M. & Hakenbeck, R.) vol. 27 199–215 (Elsevier, 1994).
- 41.Sutcliffe IC. The lipoteichoic acids and lipoglycans of Gram-positive bacteria: A chemotaxonomic perspective. Syst. Appl Microbiol. 1995;17:467–480. doi: 10.1016/S0723-2020(11)80064-0. [DOI] [Google Scholar]
- 42.Schirner K, Marles-Wright J, Lewis RJ, Errington J. Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. EMBO J. 2009;28:830–842. doi: 10.1038/emboj.2009.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Webb AJ, Karatsa-Dodgson M, Gründling A. Two-enzyme systems for glycolipid and polyglycerolphosphate lipoteichoic acid synthesis in Listeria monocytogenes. Mol. Microbiol. 2009;74:299–314. doi: 10.1111/j.1365-2958.2009.06829.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gründling A, Schneewind O. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl Acad. Sci. USA. 2007;104:8478–8483. doi: 10.1073/pnas.0701821104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Bæk KT, et al. The cell wall polymer lipoteichoic acid becomes nonessential in Staphylococcus aureus cells lacking the ClpX chaperone. mBio. 2016;7:e01228-16. doi: 10.1128/mBio.01228-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Reichmann NT, et al. Differential localization of LTA synthesis proteins and their interaction with the cell division machinery in Staphylococcus aureus. Mol. Microbiol. 2014;92:273–286. doi: 10.1111/mmi.12551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Oku Y, et al. Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J. Bacteriol. 2009;191:141–151. doi: 10.1128/JB.01221-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hesser AR, et al. The length of lipoteichoic acid polymers controls Staphylococcus aureus cell size and envelope integrity. J. Bacteriol. 2020;202:e00149–20. doi: 10.1128/JB.00149-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kovacevic S, et al. Identification of a novel protein with a role in lipoarabinomannan biosynthesis in mycobacteria. J. Biol. Chem. 2006;281:9011–9017. doi: 10.1074/jbc.M511709200. [DOI] [PubMed] [Google Scholar]
- 50.Crellin PK, et al. Mutations in pimE restore lipoarabinomannan synthesis and growth in a Mycobacterium smegmatis lpqW mutant. J. Bacteriol. 2008;190:3690–3699. doi: 10.1128/JB.00200-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Angala SK, Li W, Boot CM, Jackson M, McNeil MR. Secondary extended mannan side chains and attachment of the arabinan in mycobacterial lipoarabinomannan. Commun. Chem. 2020;3:101. doi: 10.1038/s42004-020-00356-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945. [DOI] [PubMed] [Google Scholar]
- 53.Park S-J, et al. CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates. Glycobiology. 2019;29:320–331. doi: 10.1093/glycob/cwz003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Zuber B, et al. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 2008;190:5672–5680. doi: 10.1128/JB.01919-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Rego EH, Audette RE, Rubin EJ. Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity. Nature. 2017;546:153–157. doi: 10.1038/nature22361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Veyron-Churlet R, Saliou J-M, Locht C. Protein scaffold involving MSMEG_1285 maintains cell wall organization and mediates penicillin sensitivity in mycobacteria. FEBS J. 2020;287:4415–4426. doi: 10.1111/febs.15232. [DOI] [PubMed] [Google Scholar]
- 57.Baranowski, C., Rego, E. H. & Rubin, E. J. The dream of a Mycobacterium. Microbiol. Spectr. 7, 10.1128/microbiolspec.gpp3-0008-2018 (2019). [DOI] [PubMed]
- 58.Kieser KJ, Rubin EJ. How sisters grow apart: mycobacterial growth and division. Nat. Rev. Microbiol. 2014;12:550–562. doi: 10.1038/nrmicro3299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Sambandamurthy VK, et al. Mycobacterium tuberculosis ∆RD1 ∆panCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine. 2006;24:6309–6320. doi: 10.1016/j.vaccine.2006.05.097. [DOI] [PubMed] [Google Scholar]
- 61.Hayashi JM, et al. Spatially distinct and metabolically active membrane domain in mycobacteria. Proc. Natl Acad. Sci. USA. 2016;113:5400–5405. doi: 10.1073/pnas.1525165113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Shell SS, et al. Leaderless transcripts and small proteins are common features of the mycobacterial translational landscape. PLoS Genet. 2015;11:e1005641. doi: 10.1371/journal.pgen.1005641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Rahlwes KC, et al. The cell envelope-associated phospholipid-binding protein LmeA is required for mannan polymerization in mycobacteria. J. Biol. Chem. 2017;292:17407–17417. doi: 10.1074/jbc.M117.804377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Paintdakhi A, et al. Oufti: an integrated software package for high-accuracy, high-throughput quantitative microscopy analysis. Mol. Microbiol. 2016;99:767–777. doi: 10.1111/mmi.13264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Sparks, I. L. et al. Computer code from: Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria (this paper). Zenodo 10.5281/zenodo.10701116 (2024). [DOI] [PubMed]
- 66.Eagen WJ, Baumoel LR, Osman SH, Rahlwes KC, Morita YS. Deletion of PimE mannosyltransferase results in increased copper sensitivity in Mycobacterium smegmatis. FEMS Microbiol Lett. 2018;365:fny025. doi: 10.1093/femsle/fny025. [DOI] [PubMed] [Google Scholar]
- 67.Judd JA, et al. A Mycobacterial Systems Resource for the research community. mBio. 2021;12:e02401–e02420. doi: 10.1128/mBio.02401-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Puffal J, Mayfield JA, Moody DB, Morita YS. Demethylmenaquinone methyl transferase is a membrane domain-associated protein essential for menaquinone homeostasis in Mycobacterium smegmatis. Front Microbiol. 2018;9:3145. doi: 10.3389/fmicb.2018.03145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Kado T, et al. A cell wall synthase accelerates plasma membrane partitioning in mycobacteria. eLife. 2023;12:e81924. doi: 10.7554/eLife.81924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Wong AI, Rock JM. CRISPR interference (CRISPRi) for targeted gene silencing in mycobacteria. Methods Mol. Biol. 2021;2314:343–364. doi: 10.1007/978-1-0716-1460-0_16. [DOI] [PubMed] [Google Scholar]
- 71.Mishra P, Singh U, Pandey CM, Mishra P, Pandey G. Application of Student’s t-test, analysis of variance, and covariance. Ann. Card. Anaesth. 2019;22:407–411. doi: 10.4103/aca.ACA_94_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Sparks, I. L. et al. Raw image data from: Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria (this paper). Dryad 10.5061/dryad.1vhhmgr1w (2024). [DOI] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Source data are provided with this paper. The data shown in tables, dot plots, scatter plots, and line plots in main and Supplementary Figs. are provided in the Source Data file. All original gel/blot images are also available in the Source Data file. Raw image data for Fig. 1f can be accessed through Dryad (10.5061/dryad.1vhhmgr1w)72. All other image data used to generate data in this study are available from GitHub under https://github.com/IanLairdSparks/Sparks_2023. Source data are provided with this paper.
Computer code is available from GitHub under https://github.com/IanLairdSparks/Sparks_202365.